Actinium Pharmaceuticals Inc (ATNM) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ATNM Annual Balance Sheets →
Tracking balance sheet results across Actinium Pharmaceuticals Inc to Dec 31 2024 helps illustrate how Jun 30 2026's financial position has responded to changing business conditions.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Dec 31 2024)
Assets
Cash & cash equivalent36.47
Cash & Short-term Investments36.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.27
Total Current Assets37.74
Equipment/Property/Plant Net0.70
Intangible Assets0.00
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent1.72
Total Assets40.16
Liabilities
Accounts Payable and Accrued Liabilities, Current LI8.51
Other Liabilities, Current0.75
Total Current Liabilities9.26
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent0.60
OperatingLeaseLiabilityNoncurrent0.00
Operating Lease Liability Current0.60
Finance Lease Liability Current0.01
Total Liabilities9.86
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock417.67
Retained Earnings / Accumulated Deficit-387.33
Accumulated Other Comprehensive Income-0.06
Other Equity-0.06
Common Stockholder's Equity30.30
Total Stockholder's Equity30.30
Liabilities & Stockholder's Equity40.16
4 historic quarters locked

Sign in to unlock the full Actinium Pharmaceuticals Inc balance sheet history.

About Actinium Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-086769

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.